Category: Blog

Best Peptides for Ankylosing Spondylitis — Expert Analysis

Thymalin, BPC-157, and TB-500 show promise for AS inflammation. Research explores immunomodulation, tissue repair mechanisms, and cytokine regulation

Peptides for Type 1 Diabetes — Evidence & Protocol Guide

Research-grade peptides like Thymalin and Dihexa show potential for beta-cell modulation in Type 1 diabetes — here’s the current clinical evidence.

Best Peptides for Diabetes Type 2 — Research Mechanisms

Best peptides for diabetes type 2 target insulin resistance and glucose regulation through GLP-1 agonism, AMPK activation, and beta-cell preservation

Peptides for Diabetes Type 2 — Evidence-Based Protocol

Peptides for diabetes type 2 protocol evidence guide: GLP-1 agonists reduce HbA1c 1.5–2.5%, improve insulin sensitivity, supported by Phase 3 trials.

Peptides for Insulin Resistance PCOS — Evidence Guide

Metformin reduces insulin resistance in PCOS by activating AMPK, but peptide GLP-1 agonists show superior results in clinical trials targeting both

Tesamorelin Fat Loss Protocol Dosage Timing — Precision

Tesamorelin fat loss protocol dosage timing maximizes visceral fat reduction through strategic subcutaneous injection at 2mg nightly before sleep.

Cagrilintide for Fat Loss — Research Evidence & Mechanisms

Cagrilintide targets amylin receptors to reduce caloric intake by 20-35% in clinical trials. Research shows synergistic effects with GLP-1 agonists for

AOD-9604 Fat Loss Protocol — Dosage & Timing Guide

AOD-9604 dosing runs 300–500mcg daily injected pre-fasted cardio. Timing, storage missteps, and cycle length determine lipolytic efficacy far more than

Cagrilintide Fat Loss Protocol Dosage Timing | Real Peptides

Cagrilintide fat loss protocol dosage timing requires 2.4mg weekly subcutaneous administration, titrated over 12 weeks to minimize GI side effects while

Survodutide for Fat Loss — Dual-Agonist Evidence Review

Survodutide activates GLP-1 and glucagon receptors simultaneously — Phase 2 trials show 18.6% mean weight reduction at 48 weeks with preserved lean mass.